Two reports, covering two different transcatheter pulmonary valves for separate yet related indications, reassure that an evolving field is headed in the right direction, with options expanding to a wider population of patients with congenital heart disease. Both reports came out during the 2020 Society for Cardiovascular Angiography and Interventions (SCAI) virtual meeting.
From tctMD.com
All Authors: John P. Cheatham, MD, MSCAI and Thomas K. Jones, MD, FSCAI
Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.